UPDATE: Stifel Upgrades eFFECTOR Therapeutics, Inc. (EFTR) to Buy

November 8, 2021 4:15 PM EST Send to a Friend
(Updated - November 8, 2021 4:16 PM EST)

Stifel analyst Benjamin J. Burnett upgraded eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login